The critical role of IFN for a successful response to SARS-CoV-2 is evident in severe COVID-19 patients who produce autoantibodies to IFN and in patients with life-threatening disease who have genetic deficiencies in IFN immunity (12, 13). Here, IFNA1 is linked to COVID-19.